Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Treatment Failure clinical trials
1 of 2 indexed Treatment Failure trials are currently recruiting.
Corpus placement: #7,188 of 28,707 conditions by registered trial count.
2 US clinical trials · 1 currently recruiting · #7,188 of 28,707 conditions by registered trial count
Treatment Failure: 2 US clinical trials tracked, 1 recruiting.
Treatment Failure is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. The most active sponsor is Cipherome, running 1 of these trials.
Enrollment posture brief
Registry condition treatment-failure
OPEN 1 | RECR 50% | LATE 0 | EARLY 0 | RANK #7188 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)
Treatment Failure lists 1 open slots (50% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Treatment Failure on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Treatment Failure is recruiting above its size-band peers.
1 of 2 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
2 total, page 1 of 1
Genomic and Methylation Markers in SCLC and LCNEC for Chemo-Immunotherapy Resistance Prediction (STRATUS)
Oncology Center of Biochemical Education And Research
NCT06717243
DOAC ADRs Retrospective Study on Genetic Variations
Cipherome
NCT04580589
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on Treatment Failure records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Treatment Failure trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Treatment Failure page
2 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Treatment Failure trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Cipherome sponsors the most Treatment Failure trials on record, review their full trial history before evaluating a specific study. See Cipherome's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Treatment Failure condition card totals 2 registered trials; most-linked intervention Carboplatin/Cisplatin -Etoposide - Atezolizumab; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.